SERUM ALPHA-FETOPROTEIN ESTIMATIONS AND DOUBLING TIME IN HEPATOCELLULAR-CARCINOMA - INFLUENCE OF THERAPY AND POSSIBLE VALUE IN EARLY DETECTION

被引：82

作者：

JOHNSON, PJ ^{[1
]}

WILLIAMS, R ^{[1
]}

机构：

[1] UNIV LONDON KINGS COLL HOSP,SCH MED,LIVER UNIT,LONDON SE5 9RS,ENGLAND

来源：

关键词：

D O I：

10.1093/jnci/64.6.1329

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1329 / 1332

页数：4

共 31 条

[1] ALPERT E, 1974, GASTROENTEROLOGY, V61, P136
[2] COCHRANE AMG, 1977, CANCER, V40, P609, DOI 10.1002/1097-0142(197708)40:2<609::AID-CNCR2820400203>3.0.CO
[3] 2-L
[4] HEPATOCELLULAR CARCINOMA IN GREAT-BRITAIN - INFLUENCE OF AGE, SEX, HBSAG STATUS, AND ETIOLOGY OF UNDERLYING CIRRHOSIS
JOHNSON, PJ
KRASNER, N
PORTMANN, B
EDDLESTON, ALWF
WILLIAMS, R
[J]. GUT, 1978, 19 (11) : 1022 - 1026
[5] ALPHA-FETOPROTEIN CONCENTRATIONS MEASURED BY RADIOIMMUNOASSAY IN DIAGNOSING AND EXCLUDING HEPATOCELLULAR CARCINOMA
JOHNSON, PJ
PORTMANN, B
WILLIAMS, R
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1978, 2 (6138): : 661 - 663
[6] JOHNSON PJ, 1978, LANCET, V1, P1006
[7] KRESNO SB, 1970, LANCET, V1, P1178
[8] KUBO Y, 1978, GASTROENTEROLOGY, V74, P578
[9] MATSUMOT.Y, 1974, CANCER, V34, P1602, DOI 10.1002/1097-0142(197411)34:5<1602::AID-CNCR2820340507>3.0.CO
[10] 2-4